<DOC>
	<DOCNO>NCT00691951</DOCNO>
	<brief_summary>A reduced response inhale corticosteroid ( ICS ) report smoking compare non-smoking asthmatic patient . However , comparative response currently prescribe medication combination therapy long-acting beta agonist ICS remain evaluated . No significant difference find group subject regard change asthma control pulmonary function airway inflammation follow budesonide association budesonide formoterol period 2 month . This explored large group subject .</brief_summary>
	<brief_title>Effects Budesonide &amp; Budesonide/Formoterol Smoking Asthmatic Subjects</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Budesonide , Formoterol Fumarate Drug Combination</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>Asthmatic nonsmoker exsmokers ( less 10 pack/years ) Asthmatic smoker ( 5 cigarette day 5 pack/years FEV1 great 70 % No 3 dos rescue medication ( bronchodilator ) per day Mentally legally incapacitate thus prevent inform consent obtain Other pulmonary disorder History upper respiratory tract infection last month Pregnant lactating woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2008</verification_date>
</DOC>